Pregabalin Recruiting Phase 3 Trials for Postherpetic Neuralgia Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02868801Efficacy and Safety of Pregabalin Sustained Release Tablet for Postherpetic Neuralgia